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Background: The purpose of this prospective study was to perform a head-to-head comparison of the two methods
most frequently used for evaluation of carotid plaque characteristics: Multi-detector Computed Tomography
Angiography (MDCTA) and black-blood 3 T-cardiovascular magnetic resonance (bb-CMR) with respect to their
ability to identify symptomatic carotid plaques.
Methods: 22 stroke unit patients with unilateral symptomatic carotid disease and >50% stenosis by duplex
ultrasound underwent MDCTA and bb-CMR (TOF, pre- and post-contrast fsT1w-, and fsT2w- sequences) within
15 days of symptom onset. Both symptomatic and contralateral asymptomatic sides were evaluated. By bb-CMR,
plaque morphology, composition and prevalence of complicated AHA type VI lesions (AHA-LT6) were evaluated.
By MDCTA, plaque type (non-calcified, mixed, calcified), plaque density in HU and presence of ulceration and/or
thrombus were evaluated. Sensitivity (SE), specificity (SP), positive and negative predictive value (PPV, NPV) were
calculated using a 2-by-2-table.
Results: To distinguish between symptomatic and asymptomatic plaques AHA-LT6 was the best CMR variable and
presence/absence of plaque ulceration was the best CT variable, resulting in a SE, SP, PPV and NPV of 80%, 80%,
80% and 80% for AHA-LT6 as assessed by bb-CMR and 40%, 95%, 89% and 61% for plaque ulceration as assessed
by MDCTA. The combined SE, SP, PPV and NPV of bb-CMR and MDCTA was 85%, 75%, 77% and 83%, respectively.
Conclusions: Bb-CMR is superior to MDCTA at identifying symptomatic carotid plaques, while MDCTA offers high
specificity at the cost of low sensitivity. Results were only slightly improved over bb-CMR alone when combining
both techniques.
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Table 1 Inclusion/Exclusion criteria
Inclusion criteria
Ischemic stroke (acute DWIa lesion and corresponding
acute neurological deficit of >24 h duration) in the
territory of the anterior or middle cerebral artery
<15 days
before both MDCTAb and black-blood carotid CMRc
Stenosing (i.e. luminal obstruction > 50% according
to NASCETd criteria) atherosclerotic plaque in the
internal carotid artery of the symptomatic side
as determined by duplex sonography
Exclusion criteria
Stroke etiology other than large vessel disease
Bilateral infarcts on cerebral
Known contraindications against CMR or MDCTA
Allergy to contrast material
Impaired renal function (glomerular filtration rate
< 30 ml/min)
Previous radiation therapy to head or neck
Surgical procedure within 24 h before bb-CMR
Previous interventional or surgical manipulation
of the symptomatic carotid artery (e.g. stenting,
endarterectomy)
Insufficient image quality in bb-CMR or MDCTA
aDWI = diffusion-weighted imaging bMDCTA =multi detector computed
tomography angiography cCMR = cardiovascular magnetic resonance.
dNASCET = North American Symptomatic Carotid Endarterectomy Trial.
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Extracranial large vessel disease is held responsible for
cerebral ischemic insults in up to 20% of cases [1]. It has
been shown that stenosis alone is not always a reliable
marker in the assessment of a plaque’s causality for stroke
[2]. There is increasing evidence that plaque morphologic
aspects should be taken into consideration to assess a
plaque´s vulnerability [3-5]. Accordingly, previous studies
involving CT angiography or high-resolution cardiovascu-
lar magnetic resonance (CMR) have identified morpho-
logic markers, representing plaque instability.
Using parallel imaging techniques and dedicated surface-
coils 3 T high-resolution black-blood CMR (bb-CMR)
is capable of reliably assessing plaque prevalence, morph-
ology and composition, allowing lesion classification
according to the modified AHA classification [6-10]. High-
resolution plaque imaging with modern multi-detector CT
angiography (MDCTA) delivers high spatial resolution and
also allows reliable assessment of plaque prevalence, size,
surface configuration and – to some extent – composition
in plaques with a low grade of calcification [11,12].
Using CMR plaque imaging the plaque characteristics
most closely associated with symptomatic plaques are
incorporated into lesion type VI according to the modified
AHA classification (AHA-LT6), comprised of its defining
features ruptured fibrous cap, intraplaque hemorrhage
and juxtaluminal hemorrhage/thrombus. Each of these
features as well as the general classification as AHA-LT6
plaque have shown an association with ipsilateral ischemic
cerebral events [13-15]. MDCTA is reported to have
shown a correlation of plaque surface irregularities (e.g.
ulceration), plaque density and degree of calcification
with ipsilateral symptoms [16-19]. Thus, both MDCTA
and CMR are able to detect differences in plaque charac-
teristics between symptomatic and asymptomatic plaques.
The purpose of this prospective study was to perform a
head-to-head comparison of MDCTA and bb-CMR with
respect to their ability to identify symptomatic carotid
plaques.
Methods
This study was performed in accordance with local regula-
tory legislation and approved by the institutional review
board. The methods used in the study were in accordance
with the ethical standards laid down in the Declarations of
Helsinki. This study was conducted in collaboration with
the stroke unit of the Department of Neurology of the
Ludwig-Maximilians-University Munich in 2008–2010. All
subjects gave written informed consent.
Patients
We examined 44 internal carotid arteries of 22 consecu-
tive patients. Only subjects with acute ischemic stroke
in the vascular area of an internal carotid artery with >50%stenosis as determined by duplex sonography were in-
cluded in this study. The percentage of carotid stenosis
was obtained using the NASCET method [20]. Ischemic
stroke was defined as an acute lesion on diffusion weighted
brain MR images (DWI) with a corresponding acute
neurological deficit of more than 24 hours duration.
The symptomatic artery was defined as being ipsilateral
to the DWI lesion. The carotid arteries contralateral to
the affected brain hemisphere served as asymptomatic
control group. All patients underwent extensive clinical
workup (lab, brain CMR, brain CT combined with
MDCTA of the carotids, duplex sonography of the cer-
vical arteries, 24-hour ECG, transoesophageal echocar-
diography) to determine the etiology of the ischemic




Imaging of all subjects was performed using a 3.0-T scanner
(Magnetom Verio, Siemens Healthcare, Erlangen, Germany).
To improve image quality, a dedicated four-channel sur-
face carotid coil (Machnet, Elde, Netherlands) was used.
The carotid coil was combined with a head coil and a head
holder that prevented involuntary head movement during
the scans.
Both the symptomatic and asymptomatic carotid arteries
were imaged using a previously presented multi-sequence-
protocol (time-of-flight (TOF), T2-, and, pre- and post-
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images were not evaluated due to limited additional
value for the present study. Best in-plane resolution
was 0.5 × 0.5 mm2. Images were acquired in segments
of 3.0 cm (2 mm slice-thickness × 15), centered on the
carotid bifurcation. This coverage is usually sufficient
to image the whole atherosclerotic carotid plaque [22].
Parallel imaging based on the generalized auto calibrat-
ing partially parallel acquisition (GRAPPA) algorithm was
used for all sequences with a parallel acquisition technique
(PAT) acceleration factor of 2. Post-contrast T1w images
were acquired 5 minutes after injection of 0.1 mmol/kg
(0.1 ml/kg) Gadolinium-DO3A-butrol (GADOVIST®, Bayer
Schering, Leverkusen, Germany) over an intravenous cath-
eter in an antecubital vein. Total scan time was 17:43 min.
CT angiography
As stroke patient assessment is performed by several units
in our clinical center, scans were performed on various
CT scanners: Bright Speed S (GE Healthcare), Aquilion
(Toshiba), Somatom Definition Flash (Siemens), Somatom
Definitition AS + (Siemens), Sensation 64 (Siemens). All
MDCTA images were obtained with coverage at least
from the aortic arch to the cranium using the respective
standard protocol parameters, notably a collimation of
0.625 mm or less. Non-ionic iodinated contrast material
was applied intravenously adjusted to patient weight
(Ultravist 370, Bayer Schering Pharma, Berlin, Germany,
i.e. 0.35-0.50 g iodine per kg bodyweight at an injection
rate of 4.5-6 ml/s followed by 100 ml saline at identical
flow). Axial images were reconstructed to volume ren-
dered (VR) images, which has been reported to improve
depiction of carotid plaque ulceration if used additionally
to axial scans [23]. Bone and soft tissue impairing the 360°
view of the bifurcation were manually removed from the
images. In order to prevent biases in the further reviewing
process, anonymized images of the right and left carotid
arteries were stored separately.
Image review
All images were reviewed by two radiologists with 4 and
11 years of experience blinded to the patient’s clinical
history. Classification was reached in consensus. Images
of all patients’ left carotid arteries were reviewed first,
followed by all images of the right side, in random order.
Image quality of each examination was rated on a
five-point scale (1 = very poor, 2 = poor, 3 = acceptable,
4 = good, 5 = excellent) and cases with image quality <3
were excluded. All following analyses were performed on
axial images.
On CMR images area-measurements of lumen, wall,
and components were obtained using the image analysis
tool CASCADE (University of Washington, Seattle, US).
T1w images were used for obtaining values for lumen,vessel wall and total vessel area. The normalized wall
index (NWI) was calculated by dividing the wall area
by the total vessel area. Atherosclerotic tissue compo-
nents (lipid-rich necrotic core, hemorrhage, fibrous tis-
sue, calcification) were identified and quantified based
on previously published criteria [24]. For definition of a
complicated AHA-LT6 plaque according to the modified
AHA classification [8], at least one of the following three
criteria was required: ruptured fibrous cap, intraplaque
hemorrhage or juxtaluminal hemorrhage/thrombus.
For MDCTA window settings were adjusted depend-
ing on image properties to optimize the delineation of
plaque properties [19]. The relative content of calcifica-
tion in the stenotic plaque (calcification/tissue <40%
vs. >40%) was visually quantified and categorized. As a
high grade of calcification can cause beam hardening
artifacts and thus spoil measurements in adjacent tis-
sue [25], tissue density was not measured in plaques
containing calcifications >40%. MDCTA images were eval-
uated for presence of plaque, plaque density/plaque type,
surface configuration, calcification and thrombus. Plaque
type was categorized as non-calcified, mixed, and calcified.
Calcification volume in mm3 was determined using the
standard plug-in on a Syngo MultiModality Workplace
(software version VE36A, Siemens Healthcare, Erlangen,
Germany).
Tissue attenuation was measured in representative non-
calcified plaque regions using several manually drawn
ellipsoid regions of interest (ROI) per axial slice encom-
passing at least approximately 75% of the plaque area.
Depending on plaque size, 4 to 16 ROIs with an area of
up to 2 mm2 were drawn. During this procedure calcifi-
cations and the contrast enhanced lumen were carefully
avoided. The average HU of the measured ROIs on
each axial slice was recorded. From this, a mean repre-
sentative HU-value for the whole plaque was calculated.
Based on the mean plaque HU, plaque type was catego-
rized as follows: non-calcified plaque associated with
lipid-rich necrotic core <60 HU, mixed plaque associated
with fibrous tissue 60–130 HU and calcified plaque >130
HU [26]. Plaques with calcification >40% were not mea-
sured and rated as calcified plaques. Outpouching of con-
trast material into or adjacent to the plaque of < 1 was
considered a surface irregularity, whereas ≥1 mm was con-
sidered ulceration [27].
Data analysis
Area measurements for each artery are given as average,
minimum or maximum absolute areas, as appropriate.
Plaque components are calculated as percentages of the
vessel wall. Categorical variables are presented as absolute
frequencies, while continuous variables are presented as
mean ± [SD]. Wilcoxon’s signed-rank test was used to test
differences for continuous variablesthe McNemar test was







< 50% [N(%)] 0 10 (50%) <0.001
50 – 69% [N(%)] 8 (40%) 3 (15%) 0.16
70 – 99% [N(%)] 12 (60%) 7 (35%) 0.21
Qualitative CMR Plaque Characteristics
AHA Lesion Type VI [N(%)] 16 (80%) 4 (20%) <0.001
Thin/ruptured fibrous cap
[N(%)]
12 (60%) 1 (5%) <0.001
Intraplaque hemorrhage
[N(%)]
9 (45%) 4 (20%) n.s.
Juxtaluminal hemorrhage/
thrombus [N(%)]
6 (30%) 1 (5%) n.s.
Quantitative CMR Plaque Characteristics
Mean lumen area [mm2] 6.5 ± 4.3 10.8 ± 7.5 0.05
Mean wall area [mm2] 72.2 ± 28.3 64.6 ± 20.9 0.17
Mean total vessel area [mm2] 111.1 ± 43.4 102.3 ± 36.4 0.27
NWIa 0.88 ± 0.07 0.78 ± 0.11 0.008
Lipid rich necrotic core [%] 24.5 ± 12.9 14.5 ± 14 0.08
Calcification [%] 3.6 ± 5.2 7.3 ± 6.3 0.03
Intraplaque hemorrhage [%] 11.4 ± 17 2.1 ± 4.5 0.03
MDCTAb Characteristics
Plaque Type
Non-calcified [N(%)] 12 (60%) 7 (35%) n.s.
Mixed [N(%)] 5 (25%) 10 (50%) n.s.




a NWI = normalized wall index.
bMDCTA =multi detector computed tomography angiography.
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ables. Kruskal-Wallis test was used if more than two
categories were present, e.g. degree of stenosis and of
calcification. Statistical evaluation was performed using
SPSS version 16.0 (IBM, Armonk, USA). A p-value of <0.05
was considered statistically significant. Sensitivity, specificity
positive and negative predictive values as well as odds ratios
were calculated using a 2-by-2 table.
Results
Patients
CT-Scans were of diagnostic quality in all subjects with
a mean image quality of 4.3 [±0.65]. 20 out of 22 of the
CMR examinations had an IQ ≥ 3 (90.9%) with a mean
image quality of 4.2 [±0.62]. Two patients had to be ex-
cluded due to severe motion artifacts. Consequently, a
total of 20 patients with 40 carotid arteries could be in-
cluded and evaluated in the study. Table 2 shows general
patient characteristics and cardiovascular risk factors.
CMR
CMR detected a total of 20 AHA-LT6 plaques, of which
16 (80%) were located on the symptomatic side and 4
(20%) on the asymptomatic side. This difference was sta-
tistically significant (p < 0.001). Of AHA-LT6 plaques, a
ruptured fibrous cap was found more frequently on the
symptomatic than the asymptomatic side (12/20 (60%)
vs. 1/20 (5%); p < 0.001) (Table 3). With respect to the
degree of stenosis, AHA-LT6 plaques were found in 14
out of 19 arteries (74%) with high degree stenosis (70-
99% stenosis) and in 6 out of 11 arteries (55%) with low
grade stenosis (50-69%; p = 0.43). No AHA-LT6 plaques
were encountered in vessels with a stenosis <50%. The
quantitative evaluation showed a larger normalized wall
index (NWI 0.88 vs. 0.78p = 0.008), and a tendency to-
wards a smaller luminal area for symptomatic plaquesTable 2 Demographics
Variable Value (mean [±SDa] or N (%))
Age [years] 69.9 [±8,8]
Male sex 15 (75%)








Coronary artery disease 3 (15%)
Family history of cardiovascular disease 4 (20%)
aSD = Standard Deviation.compared to the asymptomatic side (6.5 ± 4.3 mm2 vs.
10.8 ± 7.5mm2; p = 0.05). Plaque composition differed
significantly between the symptomatic and asymptomatic
side: The relative area of intraplaque hemorrhage was sig-
nificantly larger on the symptomatic side (11.4 ± 17% vs.
2.1 ± 4.5%; p = 0.03) (Table 3). Relative area of calcification
was smaller in the symptomatic group than in the asymp-
tomatic group (3.6 ± 5.2% vs. 7.3 ± 6.3%; p = 0.03). No
other statistically significant differences were found.
Figures 1, 2, and 3 show black-blood CMR and MDCTA
imaging examples of symptomatic (Figures 1 and 2) and
asymptomatic (Figure 3) carotid plaques.
Computed tomography
Vessels/plaque
Plaques were detected in all symptomatic vessels (20/20,
100%), while two vessels of the asymptomatic side showed
no sign of atherosclerosis (18/20, 90%; p = 0.49). Plaque
types on the symptomatic vs. asymptomatic side as
TOF T1w T1w CE
T2w CTA
Figure 1 Shows axial TOF, T1 weighted pre- and post-contrast
and T2 weighted high-resolution black-blood CMR and CTA
(lower right) images of an ulcerated plaque in the right internal
carotid artery of an 87-year old male patient with an acute
ischemic stroke in the territory of the right middle cerebral
artery. Note the clearly ulcerated plaque surface on both CMR and
CTA images as well as the hypersignal of the plaque in TOF and T1
weighted images corresponding to intraplaque hemorrhage (arrow).
A lack of contrast enhancement within the plaque indicates the
presence of a lipid-rich necrotic core. CTA shows a non-calcified
plaque with relatively hypodense plaque interior (mean






Figure 2 Shows axial TOF, T1 weighted pre and post contrast and T2
images of a plaque in the left internal carotid artery of a patient with
images fail to show a distinct surface defect, the fibrous cap is not entirely
hyperintense signal within the plaque in TOF and T1 weighted images in c
corresponds to an intraplaque hemorrhage (arrowhead). The relative lack o
lipid-rich necrotic core (arrow). Correspondingly, the CTA image shows a re
The hyperdense area in the dorsal wall of the plaque corresponds to a hyp
calcification. *Sternocleid muscle.
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plaque 12 (60%) vs. 7 (35%; p = 0.21) mixed plaque 5 (25%)
vs. 10 (50%; p = 0.19) and calcified plaque 3 (15%) vs. 3
(15%; p = 1) (Table 3). Calcification volumes were not sig-
nificantly different between the symptomatic (0.0820 ±
0.159 mm3) and the asymptomatic (0.0735 ± 0.077 mm3)
side (p = 0.22). Degrees of stenosis on the symptomatic vs.
asymptomatic side according to the NASCET criteria were
distributed as follows: <50% stenosis 0 (0%) vs. 10 (50%;
p < 0.001), 50-69% stenosis 8 (40%) vs. 3 (15%; p = 0.16)
and 70-99% stenosis 12 (60%) vs. 7 (35%; p = 0.21).
Kruskal-Wallis test for degree of stenosis yielded an ad-
justed H of 13.2, corresponding to a p-value of <0.001.
Differences between groups were calculated using the
McNemar test (Table 3). Stenosis <50% was only en-
countered in asymptomatic carotids. None of the vessels
were occluded.Surface
CT showed 8 vessels with ulceration on the symptomatic
side (40%) and one (5%) in an asymptomatic internal
carotid artery (p = 0.005). Multiple ulcerations within one
vessel were not observed. In one case we found ulcers in
both carotid arteries. The proportion of ulcerations in all
arteries was not significantly different between 50-69%
stenoses (3/11, 27%) compared to stenoses of




weighted high-resolution black-blood CMR and CTA (lower right)
an acute ischemic stroke on the left side. While both CMR and CT
distinguishable and was therefore by definition classified as thin. The
ombination with hypointense signal in the T2 weighted image
f contrast enhancement within the plaque indicates the presence of a
latively hypodense plaque interior (mean plaque density = 65,1 HU).
ointense signal in the MR images and is consistent with a marginal
TOF T1w T1w CE
CTAT2w
Figure 3 Shows axial TOF, T1 weighted pre- and post- contrast and T2 weighted high-resolution black-blood CMR and CTA (lower right)
images of a stable carotid plaque on the asymptomatic left side in a 66 year old patient who had suffered from right hemispheric stroke.
Both CMR and CTA images show the presence of an AHA lesion type 7 plaque in the dorsal wall of the left proximal internal carotid artery. After
administration of contrast material the thick fibrous cap is delineated as a hyperintense rim in the T1 weighted contrast enhanced images, separating
the plaque from the lumen (white arrowheads). Also note the hypointense signal of the plaque interior in the T1 weighted contrast enhanced image
as well as the hypodense area in the CTA image corresponding to a large lipid-rich necrotic core (arrow), measured at 166 HU, probably due to blooming
artifacts caused by its calcified portion. The hypointense rim in the peripheral plaque in all MR sequences and the corresponding hyperdense area in the
CTA image indicate the presence of a calcification (black arrowheads).
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Symptomatic plaques had a significantly lower density
compared to asymptomatic plaques (48.9 ± 15.6 HU vs.
61.8 ± 15.6 HU; p = 0.046). Kruskal-Wallis and McNemar
tests revealed no significant differences between symp-
tomatic and asymptomatic plaques regarding presence
of calcification. Calcification volume was not significantly
different between symptomatic and asymptomatic plaques.
Thrombus
Using MDCTA we could observe the ‘donut sign’ - a
filling defect within the lumen completely surrounded
by contrast media indicating presence of a thrombus -
in only one of the 20 symptomatic carotid arteries (5%)
versus none in the asymptomatic arteries (0%).
Best predictors
AHA-LT6 as single predictor for the symptomatic side re-




Ulceration and AHA-LT6 (CTA + CMR) 85%
Thin/ruptured fibrous cap 60%
aMDCTA =multi detector computed tomography angiography.
bAHA-LT6 = American Heart Association lesion type VI.
cCMR = cardiovascular magnetic resonance.80%, 80% and 80%, respectively, yielding an accuracy of
80% and an odds ratio of 16.0 (95% confidence interval:
2.8-108.9). With CMR, 4 out of 20 symptomatic plaques
were not predicted correctly. In one of these 4 patients,
MDCTA was able to detect an ulcerated plaque.
When a thin or ruptured fibrous cap was used as sin-
gle predictor, sensitivity, specificity, PPV and NPV were
60%, 95%, 92% and 70%, respectively. The accuracy was
calculated at 77.5% the odds ratio was 28.5 (95% confi-
dence interval 3.2-257.5).
Using ulceration in MDCTA as single predictor for the
symptomatic side led to a sensitivity, specificity, PPV and
a NPV of 40%, 95%, 89% and 61%, accuracy of 67.5% and
an odds ratio of 12.7 (95% confidence interval: 1.3-306).
Ulcer as detected in CT combined with AHA-LT6
Plaque in CMR led to a sensitivity of 85%, specificity of
75%, a PPV of 77% and a NPV of 83%, yielding an accur-
acy of 80% and an odds ratio of 17.0 (95% confidence
interval: 2.8-121.2; Table 4).Specificity PPV NPV Odds ratio
95% 89% 61% 12.7
80% 80% 80% 16.0
75% 77% 83% 17.0























AHA-LT6 (MRI) + Ulcer (CTA)
Ulcer
Thin or Ruptured Fibrous Cap
Figure 4 Shows the ROC graph of various variables. Lines are dotted where only one value was present. Note that especially AHA-LT6 with
and without ulcer in CTA as well as thin or ruptured fibrous cap show high sensitivity and specificity, while plaque density in HU and volume of
calcification are not suitable as predictors of the symptomatic side.
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presented variables and their respective sensitivity and
specificity.
Discussion
This study shows that both MDCTA and bb-CMR of the
carotid arteries are able to detect differences between
symptomatic and asymptomatic plaques in patients with
ischemic large vessel stroke. CMR using AHA-LT6 as
single criterion showed higher sensitivity, negative pre-
dictive value and accuracy than ulceration as the best
MDCTA variable while the latter delivered a better spe-
cificity and positive predictive value but suffered from a
low sensitivity. Even better specificity and positive pre-
dictive values were found when using a thin or ruptured
fibrous cap as detected on bb-CMR as single predictor.
Prediction of the symptomatic side was minimally en-
hanced when information from both MDCTA and CMR
were combined.
AHA-LT6
Complicated AHA-LT6 plaques were more frequently
encountered in symptomatic than in asymptomatic ar-
teries (80% vs. 20%, p < 0.001). Consequently type III, IV,
V and VII, which reflect clinically more stable plaques,
were more common in asymptomatic vessels. These re-
sults are in line with findings of Saam et al. who found a
statistically significant association between complicated
AHA-LT6 carotid plaques and ipsilateral symptoms in acohort of 23 symptomatic patients who underwent CMR-
plaque imaging [13]. This makes AHA-LT6 a useful
parameter for risk assessment in atherosclerotic carotid
plaques. In our study, as a single criterion, the presence of
an AHA-LT6 plaque proved to be the best overall pre-
dictor for the symptomatic side.
We noted a greater frequency of AHA-LT6 plaques in
high degree stenoses compared to low degree stenoses.
Even though not statistically significant, this result is in
line with findings of previous studies [28,29], which re-
port an increasing prevalence of vulnerable plaques with
increasing degree of stenosis.
Ulceration
Former studies could show that ulceration of the carotid
arteries is associated with cerebral lesions and is encoun-
tered more frequently in symptomatic patients [17,30-32].
The present study found ulcerations with a prevalence of
40% in symptomatic carotid arteries and in 5% of the
asymptomatic arteries. Overall prevalence of ulceration
was 32% in high grade stenoses (70-99%), 27% in low
grade stenoses (50-69%) and 0% in non-stenosed arteries.
The reported prevalence of plaque ulceration in our study
is similar to the NASCET study, which reported ulcera-
tions in 35% of vessels with a stenosis >70% as detected by
DSA [33].
In our study, using ulceration in MDCTA as the sole
predictor for the symptomatic side led to a relatively low
sensitivity but a high specificity. The lower sensitivity
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are hard to detect in MDCTA, such as rupture of the fi-
brous cap or intraplaque hemorrhage potentially followed
by thrombus formation and consequent embolisation may
also cause cerebrovascular incidents.
Other factors
While other plaque properties analyzed in this study
failed to reach the predictive power of AHA-LT6 or
plaque ulceration, they may still be useful for plaque
characterization and general risk assessment.
Analysis of the plaque density showed that plaques on
the symptomatic side had significantly lower HU values
than asymptomatic plaques. This may be due to higher
lipid content and confirms the findings of other studies
by Saba et al. [30] and Serfaty et al. [25] which both
found a statistically significant association between fatty
plaque or decreased plaque density and neurological
symptoms in cohorts of 112 and 141 patients. Trelles et al.
similarly found a greater thickness of the non-calcified
plaque component in AHA-LT6 plaques in a study on 51
stroke patients [34]. These results are also in line with pre-
vious observations in coronary plaques which suggested
that plaques with a large lipid-rich/necrotic core strongly
correlate with formation of thrombi and plaque disruption
[35]. Despite these differences in HU, a reliable cut-off
point to distinguish symptomatic from asymptomatic
plaques has not yet been determined [19].
Juxtaluminal hemorrhage/thrombus impose a high risk
of distal embolization and thus thrombotic occlusion of
a distal vessel. In a previous histological study with 241
patients Fisher et al. observed that thrombus is highly
associated with ipsilateral symptoms and plaque ulcer-
ation (p < 0.005) [33]. Using MDCTA we could identify a
fresh thrombus (“donut sign”) in only one carotid artery
(2.5%). CMR, however, showed juxtaluminal hemorrhage/
thrombus in 30% of the symptomatic and 5% of the
asymptomatic arteries. Our study thus shows that for de-
tection of juxtaluminal hemorrhage/thrombus CMR is
more sensitive than MDCTA, a fact that may be attributed
to MDCTA’s comparatively poor soft tissue contrast and
its inability to identify the fibrous cap and intraplaque
hemorrhage. In 6 out of 7 cases thrombi detected by CMR
were associated with a rupture of the fibrous cap. This
supports the thesis that thrombi evolve from surface de-
fects of plaques presenting thrombogenic components.
In our study a thin or ruptured fibrous cap itself was
closely associated with the symptomatic side (OR 28.5).
This may be attributed to thrombogenic potency of sur-
face defects of the fibrous cap with subsequent forma-
tion of unstable thrombi, potentially causing embolism.
Our results indicate that a thin or ruptured fibrous cap
may be a more accurate predictor than juxtaluminal
hemorrhage/thrombus. Compared to AHA-LT6, a thinor ruptured fibrous cap as single predictor showed su-
perior specificity and positive predictive value, while
sensitivity and negative predictive value were inferior.
Because of its high specificity and positive predictive
value a thin or ruptured fibrous cap may be a factor to
be considered separately.
Bb-CMR or MDCTA?
Based on the data of our study bb-CMR is better suited
than MDCTA to identify symptomatic carotid plaques.
This is mainly owed to the better detection of subtle
plaque features on bb-CMR. In order to further assess
the potential of bb-CMR, several prospective studies, such
as the CAPIAS trial (NCT01284933) [36] or the PARISK
study (NCT01208025) are currently under way which
examine the ability of carotid bb-CMR to predict recur-
rence of ischemic stroke in patients with less than 70%
stenosis.
While the diagnostic value of bb-CMR regarding the
characterization of carotid plaques cannot reasonably be
disputed, it is still not routinely applied in many centers.
This may be attributed to a generally lower availability
of suitable CMR equipment and longer scan times of
bb-CMR compared to MDCTA, requiring a higher degree
of patient cooperation. Another limiting factor for carotid
CMR in the acute setting is the narrow time window for
treating acute strokes, so examination times need to be
kept reasonably short. It needs to be noted that the use of
a dedicated carotid coil, which is not available at every
center, enhances MR image quality. However, with careful
design of the examination and its sequence parameters,
image quality should be sufficient to determine the major
plaque features even without such a dedicated coil.
On the other hand, MDCTA requires application of a
considerable amount of ionizing radiation and, more im-
portantly, iodinated contrast agent with the known ad-
verse effects, especially in the patient population with
cardiovascular risk factors. Logistically, bb-CMR of the
carotids can be performed immediately following brain
CMR with reasonable extension of the examination time,
which will at least in part be compensated by avoiding a
transfer of the patient between the CT and CMR device.
Limitations
One limitation of this study is the use of different CT
scanners, so that examination parameters are not com-
pletely identical. We chose to include examinations from
various CT scanners to increase the number of patients
and accounted for possible differences in image acquisi-
tion parameters by applying a uniform image quality
score to all images.
Furthermore, our study followed a cross sectional design
by examining patients who were already symptomatic. To
assess the predictive value of different plaque characteristics
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dinal studies are necessary. It should be noted that our
study population contains a comparatively large number
of vessels with high degree stenoses. This is owed to the
inclusion criteria requiring ≥50% stenosis in the artery ip-
silateral to the ischemic stroke and does not represent the
prevalence of high degree stenosis in the general popula-
tion. It needs to be noted that we performed all tests on
subjects of a symptomatic population where by definition
the prevalence of symptomatic carotid plaques is 100%.
This may influence the absolute validity of sensitivity, spe-
cificity, positive and negative predictive values for the re-
ported plaque features at predicting the symptomatic side.
It should, however, not significantly impair the compar-
ability of the different predictors with each other.
3D sequences were not part of this study. While these
might have increased the arterial coverage or decreased
examination times, we chose to not apply them in this
study because they are less well validated and may provide
less spatial in-plane resolution. Furthermore, coverage of
the 2D sequences used was sufficient to depict the entire
plaque in each case so that it seemed safe to use the previ-
ously established 2D protocol, which has proven to deliver
excellent image quality while being robust and reliable.
We did not use contrast enhanced MR angiography
(CEMRA) because we performed perfusion imaging of the
plaques, which was not evaluated for this study. Evaluation
of CEMRA might have increased the sensitivity of CMR
to detect surface irregularities in carotid plaques. However,
several studies have shown that ulcerations are an unreli-
able predictor of patient’s symptoms and we therefore be-
lieve that while CEMRA might have further accentuated
the superiority of CMR, this would not have significantly
changed our conclusion.
Conclusions
Bb-CMR is superior to MDCTA at detecting symptomatic
plaques. Predictive power of CMR using AHA-LT6 is only
slightly enhanced if combined with ulceration from
MDCTA. Presence of a thin or ruptured fibrous cap on
MR images may be a useful individual property for pre-
dicting the presence of symptoms due to its excellent spe-
cificity and positive predictive value. Although MDCTA
has a lower sensitivity to identify the symptomatic side, it
does offer some insights into plaque vulnerability and re-
mains useful in patients who cannot undergo CMR.
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